A 6087: Requires health insurance policies to fully cover multi-marker testing related to ovarian cancer to patients which have been diagnosed with an ovarian adnexal mass.
What A 6087 does, verified January 8, 2026
The bill requires health insurance policies to cover multi-marker testing related to ovarian cancer for patients diagnosed with an ovarian adnexal mass. This coverage must be provided without annual deductibles and coinsurance, and the insurer must bear the cost. The bill also applies to group and blanket policies, as well as medical expense indemnity corporations, hospital service corporations, and health service corporations. The new requirements take effect on the first of January following the bill's enactment date and apply to policies issued, reissued, renewed, modified, or amended on or after that date.
Bill journey
1IntroducedCurrent
2In CommitteePending
3First Chamber FloorPending
4Second ChamberPending
5GovernorPending
6ChapteredPending
Last action: referred to insurance (2026-01-07)Alert me
Quick answers about A 6087
- What is the current status of A 6087?
- As of January 8, 2026, A 6087 is recorded as "Introduced": it has been introduced and is waiting for its first committee hearing or floor vote. The last recorded action, on January 7, 2026, was "referred to insurance".
- Did A 6087 pass?
- Not yet. A 6087 has been introduced and has not passed either house.
- Who wrote A 6087, and where is it now?
- A 6087 was authored by Asm. Pamela Hunter with 1 coauthor. Its committee of record is Assembly Insurance. It is filed under ISC, alongside 202 other New York ISC bills this session.
Author and sponsors
Full contact details, staff, and committees with Connect, $16/moUnlockRecent actions2 total · showing 2
| Jan. 07, 2026 | referred to insurance |
| Feb. 26, 2025 | referred to insurance |
Latest bill textIntroduced version, February 26, 2025 · 502 words
STATE OF NEW YORK ________________________________________________________________________ 6087 2025-2026 Regular Sessions IN ASSEMBLY February 26, 2025 ___________ Introduced by M. of A. HUNTER -- read once and referred to the Committee on Insurance AN ACT to amend the insurance law and the social services law, in relation to requiring health insurance policies to fully cover multi- marker testing related to ovarian cancer to patients which have been diagnosed with an ovarian adnexal mass The People of the State of New York, represented in Senate and Assem- bly, do enact as follows: 1 Section 1. Subsection (i) of section 3216 of the insurance law is 2 amended by adding a new paragraph 11-d to read as follows: 3 (11-d) (A) Every policy that provides coverage for hospital, surgical 4 or medical care shall offer full coverage for multi-marker testing 5 related to ovarian cancer to patients which have been diagnosed with an 6 ovarian adnexal mass. 7 (B) Such additional coverage shall not be subject to annual deduct- 8 ibles and coinsurance but shall be borne solely by the insurer. 9 § 2. Subsection (l) of section 3221 of the insurance law is amended by 10 adding a new paragraph 11-d to read as follows: 11 (11-d) (A) Every insurer delivering a group or blanket policy or issu- 12 ing a group or blanket policy for delivery in this state that provides 13 coverage for hospital, surgical or medical care shall offer full cover- 14 age for multi-marker testing related to ovarian cancer to patients which 15 have been diagnosed with an ovarian adnexal mass. 16 (B) Such additional coverage shall not be subject to annual deduct- 17 ibles and coinsurance but shall be borne solely by the insurer. 18 § 3. Section 4303 of the insurance law is amended by adding a new 19 subsection (p-2) to read as follows: 20 (p-2) (1) A medical expense indemnity corporation, a hospital service 21 corporation or a health service corporation that provides coverage for 22 hospital, surgical or medical care shall offer full coverage for multi- EXPLANATION--Matter in italics (underscored) is new; matter in brackets [] is old law to be omitted. LBD09829-01-5A. 6087 2 1 marker testing related to ovarian cancer to patients which have been 2 diagnosed with an ovarian adnexal mass. 3 (2) Such additional coverage shall not be subject to annual deduct- 4 ibles and coinsurance but shall be borne solely by the insurer. 5 § 4. Subdivision 2 of section 365-a of the social services law is 6 amended by adding a new paragraph (nn) to read as follows: 7 (nn) multi-marker testing related to ovarian cancer to patients which 8 have been diagnosed with an ovarian adnexal mass. 9 § 5. This act shall take effect on the first of January next succeed- 10 ing the date on which it shall have become a law and shall apply to 11 policies issued, reissued, renewed, modified or amended on or after such 12 date.
Text of A 6087 as introduced, from the official record. Connect Plus keeps every version and highlights what changed.Compare versions